Clinical trial
Rare and Atypical Diabetes Network
NCT05544266
Study timeline
Study start (actual)2020-09-30Date precision: day
Registry last updated2025-08-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitusunresolved
Diabetes Mellitus Progressionunresolved
Glucose Intoleranceunresolved
Glucose Metabolism Disordersunresolved
Metabolic Diseaseunresolved
Endocrine; Complicationsunresolved
Endocrine System Diseasesunresolved
Interventions
Sponsors & collaborators
Mapped research locations
New YorkNew York, United States1HoustonTexas, United States1BostonMassachusetts, United States1ChicagoIllinois, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1NashvilleTennessee, United States1SeattleWashington, United States1IndianapolisIndiana, United States1AuroraColorado, United States1Ann ArborMichigan, United States1Chapel HillNorth Carolina, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05544266 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.